DSCO Windtree Therapeutics Com

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No.  1)

Filed by the Registrant  x

Filed by a Party other than the Registrant  o

Check the appropriate box:

o

Preliminary Proxy Statement

o

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

x

Definitive Proxy Statement

o

Definitive Additional Materials

o

Soliciting Material under §240.14a-12

Discovery Labs, Inc

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

x

No fee required.

o

Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

(1)

Title of each class of securities to which transaction applies:

(2)

Aggregate number of securities to which transaction applies:

(3)

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

(4)

Proposed maximum aggregate value of transaction:

(5)

Total fee paid:

o

Fee paid previously with preliminary materials.

o

Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

(1)

Amount Previously Paid:

(2)

Form, Schedule or Registration Statement No.:

(3)

Filing Party:

(4)

Date Filed:

Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Status

Number of
Shares of
Common Stock
Authorized (1)

Number of
Shares of
Common
Stock
Issued and
Outstanding(2)

Number of
Shares of
Common
Stock
Reserved for
Future
Issuance

Number of Shares of
Common Stock
Authorized and
Available for
Issuance

Pre-Reverse Split

250,000,000

112,064,773

134,779,758

3,155,469

Post-Reverse Split 1:10

50,000,000

11,206,477

13,477,976

25,315,547 315,547

Post-Reverse Split 1:12

42,000,000

9,338,731

11,231,647

21,429,622 262,956

Post-Reverse Split 1:15

34,000,000

7,470,985

8,985,317

17,543,698 210,365

Post-Reverse Split 1:18

28,000,000

6,225,821

7,487,764

14,286,415 175,304

Post Reverse Split 1:20

25,000,000

5,603,239

6,738,988

12,657,773 157,773